GBGI Now Offers New Technology Barrett’s Esophagus Testing
Barrett’s Esophagus is a potentially serious pre-cancerous condition of the esophagus that occurs silently in 15% of GERD patients and that requires lifelong follow up to be sure the condition does not progress. It can be seen in any patient at any age but classically effects white men over 50 and other patients at risk such as those with:
- Prolonged GERD
- Symptoms (>5 years)
- A family history of BE and/or adenocarcinoma of the esophagus
- Nocturnal reflux symptoms
- Hiatal hernia
- Increased body mass index (BMI>35)
- Tobacco use
- Intra-abdominal distribution of fat
While only 1 percent of Barrett’s patients ever develop more advanced lining changes or cancer that is 30-60x more often than the general population.
Greater Boston GI, at all of its facilities, offers a new technology that allows better and more accurate detection and staging of Barrett’s called the WATS3D assay. Learn more about the test here.